BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

626 related articles for article (PubMed ID: 6238627)

  • 21. Association of calmodulin with peptide analogues of the inhibitory region of the heat-stable protein inhibitor of adenosine cyclic 3',5'-phosphate dependent protein kinase.
    Malencik DA; Scott JD; Fischer EH; Krebs EG; Anderson SR
    Biochemistry; 1986 Jun; 25(12):3502-08. PubMed ID: 3755057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyamines inhibit phospholipid-sensitive and calmodulin-sensitive Ca2+-dependent protein kinases.
    Qi DF; Schatzman RC; Mazzei GJ; Turner RS; Raynor RL; Liao S; Kuo JF
    Biochem J; 1983 Aug; 213(2):281-8. PubMed ID: 6615435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of inhibitors of intracellular messenger systems on amylase release from rat parotid gland.
    Hashioka T; Kato M
    Aichi Gakuin Dent Sci; 1990; 3():59-66. PubMed ID: 1718407
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of signal-regulated protein kinases by plant-derived hydrolysable tannins.
    Polya GM; Wang BH; Foo LY
    Phytochemistry; 1995 Jan; 38(2):307-14. PubMed ID: 7772301
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-(2-Aminoethyl)-5-isoquinolinesulfonamide, a newly synthesized protein kinase inhibitor, functions as a ligand in affinity chromatography. Purification of Ca2+-activated, phospholipid-dependent and other protein kinases.
    Inagaki M; Watanabe M; Hidaka H
    J Biol Chem; 1985 Mar; 260(5):2922-5. PubMed ID: 2982842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific binding of a novel compound, N-[2-(methylamino)ethyl]-5-isoquinolinesulfonamide (H-8) to the active site of cAMP-dependent protein kinase.
    Hagiwara M; Inagaki M; Hidaka H
    Mol Pharmacol; 1987 May; 31(5):523-8. PubMed ID: 3574296
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of a new Ca2(+)-calmodulin-dependent protein kinase II inhibitor on GABA release in cerebrospinal fluid of the rat.
    Ishikawa N; Hashiba Y; Hidaka H
    J Pharmacol Exp Ther; 1990 Aug; 254(2):598-602. PubMed ID: 2384887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of chicken gizzard myosin light-chain kinase, and its calcium and strontium sensitivities as compared with those of superprecipitation and ATPase activities of actomyosin.
    Uchiwa H; Kato T; Onishi H; Isobe T; Okuyama T; Watanabe S
    J Biochem; 1982 Jan; 91(1):273-82. PubMed ID: 6461641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relaxation of vascular smooth muscle by HA-1004, an inhibitor of cyclic nucleotide-dependent protein kinase.
    Ishikawa T; Inagaki M; Watanabe M; Hidaka H
    J Pharmacol Exp Ther; 1985 Nov; 235(2):495-9. PubMed ID: 2997436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potent and preferential inhibition of Ca2+/calmodulin-dependent protein kinase II by K252a and its derivative, KT5926.
    Hashimoto Y; Nakayama T; Teramoto T; Kato H; Watanabe T; Kinoshita M; Tsukamoto K; Tokunaga K; Kurokawa K; Nakanishi S
    Biochem Biophys Res Commun; 1991 Nov; 181(1):423-9. PubMed ID: 1659814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Ca2+ -activated protease (calpain) modulates Ca2+/calmodulin dependent activity of smooth muscle myosin light chain kinase.
    Ito M; Tanaka T; Nunoki K; Hidaka H; Suzuki K
    Biochem Biophys Res Commun; 1987 Jun; 145(3):1321-8. PubMed ID: 3038096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of protein kinase C in interleukin 1 and tumor necrosis factor alpha induction of fibroblasts to produce and release granulocyte-macrophage colony-stimulating activity.
    Zucali JR; Morse C; Dinarello CA
    Exp Hematol; 1990 Sep; 18(8):888-92. PubMed ID: 2167234
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symmetric covalent linkage of N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7) results in novel derivatives with increased inhibitory activities against calcium/calmodulin complex.
    Yokokura H; Osawa M; Inoue T; Umezawa I; Naito Y; Ikura M; Hidaka H
    Drug Des Discov; 1999 Nov; 16(3):203-16. PubMed ID: 10624566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of eukaryote protein kinases by isoquinoline and oxazine alkaloids.
    Wang BH; Lu ZX; Polya GM
    Planta Med; 1997 Dec; 63(6):494-8. PubMed ID: 9434598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific inhibition of cyclic AMP-dependent protein kinase by the antimalarial halofantrine and by related phenanthrenes.
    Wang BH; Ternai B; Polya GM
    Biol Chem Hoppe Seyler; 1994 Aug; 375(8):527-35. PubMed ID: 7811392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calponin-calmodulin interaction: properties and effects on smooth and skeletal muscle actin binding and actomyosin ATPases.
    Winder SJ; Walsh MP; Vasulka C; Johnson JD
    Biochemistry; 1993 Dec; 32(48):13327-33. PubMed ID: 8241189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rationally designed PKA inhibitors for positron emission tomography: Synthesis and cerebral biodistribution of N-(2-(4-bromocinnamylamino)ethyl)-N-[11C]methyl-isoquinoline-5-sulfonamide.
    Vasdev N; LaRonde FJ; Woodgett JR; Garcia A; Rubie EA; Meyer JH; Houle S; Wilson AA
    Bioorg Med Chem; 2008 May; 16(9):5277-84. PubMed ID: 18346896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.
    Collins I; Caldwell J; Fonseca T; Donald A; Bavetsias V; Hunter LJ; Garrett MD; Rowlands MG; Aherne GW; Davies TG; Berdini V; Woodhead SJ; Davis D; Seavers LC; Wyatt PG; Workman P; McDonald E
    Bioorg Med Chem; 2006 Feb; 14(4):1255-73. PubMed ID: 16249095
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calmodulin-linked equilibria in smooth muscle myosin light chain kinase.
    Malencik DA; Anderson SR
    Biochemistry; 1986 Feb; 25(3):709-21. PubMed ID: 3754154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition of eukaryote protein kinases by condensed tannins.
    Wang BH; Foo LY; Polya GM
    Phytochemistry; 1996 Sep; 43(2):359-65. PubMed ID: 8862029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.